AIM
TDOC icon

Acrospire Investment Management’s Teladoc Health TDOC Stock Holding History

Acrospire Investment Management’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1,409
Closed -$23K – 2483
2016
Q4 		$23K Buy
1,409
+1,100
+356% +$18.7K 0.01% 1714
2016
Q3 		$6K Buy
+309
New +$5.42K ﹤0.01% 1800

Other funds holding TDOC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Tiger Global Management
Tiger Global Management New York $24B AUM 39.59% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Acrospire Investment Management's TDOC Position: Q1 2017 in Review

Acrospire Investment Management sold out of Teladoc Health (TDOC) in Q1 2017, closing a stake of 1,409 shares — an estimated $23K sold.

Acrospire Investment Management first reported a position in TDOC in Q3 2016 and held it in 2 quarters. The position peaked at $23K in Q4 2016. 132 funds tracked by Wall St. Rank hold TDOC as of Q1 2017.

  • Acrospire Investment Management reported no remaining Teladoc Health position as of Q1 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 1,409 Teladoc Health shares in Q1 2017, an estimated $23K.
  • Acrospire Investment Management first reported a position in Teladoc Health in Q3 2016 and held it in 2 quarters.
  • Acrospire Investment Management's Teladoc Health position peaked at $23K in Q4 2016.
  • 132 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2017.

Based on Acrospire Investment Management's 13F filing for Q1 2017, filed 4 May 2017.